RORA (RAR-related orphan receptor alpha) is a nuclear receptor that functions as a key transcriptional regulator binding DNA as a monomer to ROR response elements containing the core motif 5'-AGGTCA-3'. It serves critical roles in embryonic development, cellular differentiation, circadian rhythm regulation, and metabolic homeostasis [UniProt]. RORA regulates circadian clock genes including CLOCK, BMAL1, NPAS2, and CRY1, competing with NR1D1 to modulate their expression and influence circadian period stability [UniProt]. The receptor controls lipid and glucose metabolism through transcriptional regulation of metabolic genes such as APOA1, APOC3, and G6PC1 [UniProt], and acts as a negative regulator of adipocyte differentiation [UniProt]. In immune contexts, RORA promotes Th17 cell lineage specification downstream of IL6 and TGFB [UniProt] and enhances anti-tumor immunity by suppressing PD-L1 expression through formation of an inhibitory complex with HDAC3 1. RORA also regulates photoreceptor development and is required for proper cerebellum development [UniProt, 29]. In corneal epithelial differentiation, RORA acts as a CEC-specific molecular switch driving LSC differentiation through PITX1 activation and epigenetic remodeling 3. RORA functions as a metabolic regulator governing hepatic stellate cell commitment and fibrosis, with expression inversely correlating with liver fibrosis severity 4. Disease associations include intellectual developmental disorder with or without epilepsy or cerebellar ataxia [NCBI], and RORA gene therapy is under investigation for Stargardt's disease to address oxidative stress and inflammation 5.